Cargando…
Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647074/ https://www.ncbi.nlm.nih.gov/pubmed/33157549 http://dx.doi.org/10.1371/journal.pone.0241909 |
_version_ | 1783606882632466432 |
---|---|
author | Hatah, Ernieda Rahim, Nadiah Makmor-Bakry, Mohd Mohamed Shah, Noraida Mohamad, Noraini Ahmad, Mahadir Haron, Nor Hasni Sze Hwe, Choe Tan Meng Wah, Angeline Hassan, Fahmi Shaik Rahmat, Shakirin Robert, Sarah Ann Abdullah, Noraidatulakma |
author_facet | Hatah, Ernieda Rahim, Nadiah Makmor-Bakry, Mohd Mohamed Shah, Noraida Mohamad, Noraini Ahmad, Mahadir Haron, Nor Hasni Sze Hwe, Choe Tan Meng Wah, Angeline Hassan, Fahmi Shaik Rahmat, Shakirin Robert, Sarah Ann Abdullah, Noraidatulakma |
author_sort | Hatah, Ernieda |
collection | PubMed |
description | Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical because it requires a license and currently every form used is charged. Hence, there is a need to develop and validate a new medication adherence tool. The Malaysia Medication Adherence Assessment Tool (MyMAAT) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. The face and content validities of the MyMAAT was established by a panel of experts. A total of 495 patients with type 2 diabetes were recruited from the Ministry of Health facilities consisting of five hospitals and five primary health clinics. A test-retest was conducted on 42 of the patients one week following their first data collection. Exploratory factor analysis was performed to evaluate the validity of the MyMAAT. The final item for MyMAAT was compared with SEAMS, HbA(1c)%, Medication Possession ratio (MPR) score, and pharmacist’s subjective assessment for its hypothesis testing validity. The MyMAAT-12 achieved acceptable internal consistency (Cronbach’s alpha = 0.910) and stable reliability as the test-retest score showed good to excellent correlation (Spearman’s rho = 0.96, p = 0.001). The MyMAAT has significant moderate association with SEAMS (Spearman’s rho = 0.44, p = < 0.001) and significant relationship with HbA1c (< 8% and ≥ 8%) (χ(2)(1) = 13.4, p < 0.001), MPR (χ(2)(1) = 13.6, p < 0.001) and pharmacist’s subjective assessment categories (χ(2)(1) = 31, p < 0.001). The sensitivity of MyMAAT-12, tested against HbA1c% was 72.9% while its specificity was 43%. This study demonstrates that the MyMAAT-12 together with other methods of assessment may make a better screening tool to identify patients who were non-adherence to their medications. |
format | Online Article Text |
id | pubmed-7647074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-76470742020-11-16 Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients Hatah, Ernieda Rahim, Nadiah Makmor-Bakry, Mohd Mohamed Shah, Noraida Mohamad, Noraini Ahmad, Mahadir Haron, Nor Hasni Sze Hwe, Choe Tan Meng Wah, Angeline Hassan, Fahmi Shaik Rahmat, Shakirin Robert, Sarah Ann Abdullah, Noraidatulakma PLoS One Research Article Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical because it requires a license and currently every form used is charged. Hence, there is a need to develop and validate a new medication adherence tool. The Malaysia Medication Adherence Assessment Tool (MyMAAT) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. The face and content validities of the MyMAAT was established by a panel of experts. A total of 495 patients with type 2 diabetes were recruited from the Ministry of Health facilities consisting of five hospitals and five primary health clinics. A test-retest was conducted on 42 of the patients one week following their first data collection. Exploratory factor analysis was performed to evaluate the validity of the MyMAAT. The final item for MyMAAT was compared with SEAMS, HbA(1c)%, Medication Possession ratio (MPR) score, and pharmacist’s subjective assessment for its hypothesis testing validity. The MyMAAT-12 achieved acceptable internal consistency (Cronbach’s alpha = 0.910) and stable reliability as the test-retest score showed good to excellent correlation (Spearman’s rho = 0.96, p = 0.001). The MyMAAT has significant moderate association with SEAMS (Spearman’s rho = 0.44, p = < 0.001) and significant relationship with HbA1c (< 8% and ≥ 8%) (χ(2)(1) = 13.4, p < 0.001), MPR (χ(2)(1) = 13.6, p < 0.001) and pharmacist’s subjective assessment categories (χ(2)(1) = 31, p < 0.001). The sensitivity of MyMAAT-12, tested against HbA1c% was 72.9% while its specificity was 43%. This study demonstrates that the MyMAAT-12 together with other methods of assessment may make a better screening tool to identify patients who were non-adherence to their medications. Public Library of Science 2020-11-06 /pmc/articles/PMC7647074/ /pubmed/33157549 http://dx.doi.org/10.1371/journal.pone.0241909 Text en © 2020 Hatah et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hatah, Ernieda Rahim, Nadiah Makmor-Bakry, Mohd Mohamed Shah, Noraida Mohamad, Noraini Ahmad, Mahadir Haron, Nor Hasni Sze Hwe, Choe Tan Meng Wah, Angeline Hassan, Fahmi Shaik Rahmat, Shakirin Robert, Sarah Ann Abdullah, Noraidatulakma Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title | Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title_full | Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title_fullStr | Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title_full_unstemmed | Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title_short | Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients |
title_sort | development and validation of malaysia medication adherence assessment tool (mymaat) for diabetic patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647074/ https://www.ncbi.nlm.nih.gov/pubmed/33157549 http://dx.doi.org/10.1371/journal.pone.0241909 |
work_keys_str_mv | AT hatahernieda developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT rahimnadiah developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT makmorbakrymohd developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT mohamedshahnoraida developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT mohamadnoraini developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT ahmadmahadir developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT haronnorhasni developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT szehwechoe developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT tanmengwahangeline developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT hassanfahmi developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT shaikrahmatshakirin developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT robertsarahann developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients AT abdullahnoraidatulakma developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients |